BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7484027)

  • 1. Comparison of the effects of neostigmine and edrophonium on the duration of action of suxamethonium.
    McCoy EP; Mirakhur RK
    Acta Anaesthesiol Scand; 1995 Aug; 39(6):744-7. PubMed ID: 7484027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine.
    Fleming NW; Macres S; Antognini JF; Vengco J
    Br J Anaesth; 1996 Oct; 77(4):492-5. PubMed ID: 8942334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neostigmine but not edrophonium prolongs the action of mivacurium.
    Symington MJ; Mirakhur RK; Kumar N
    Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cholinesterase inhibitors on the neuromuscular blocking action of suxamethonium.
    Valdrighi JB; Fleming NW; Smith BK; Baker GL; White DA
    Br J Anaesth; 1994 Feb; 72(2):237-9. PubMed ID: 8110583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of mivacurium neuromuscular block: neostigmine versus edrophonium.
    Devcic A; Munshi CA; Gandhi SK; Kampine JP
    Anesth Analg; 1995 Nov; 81(5):1005-9. PubMed ID: 7486038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of edrophonium and neostigmine for the antagonism of atracurium-induced neuromuscular block.
    Lavery GG; Mirakhur RK; Gibson FM
    Anesth Analg; 1985 Sep; 64(9):867-70. PubMed ID: 3161421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M; Riad W
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade].
    Bartunek A; Gilly H; Huemer G; Yildiz S; Schramm W; Lackner FX; Foldes FF
    Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atracurium after an anticholinesterase. Does prior reversal with edrophonium or neostigmine influence the response to atracurium?
    Shorten GD; Ali HA
    Anaesthesia; 1993 Jun; 48(6):524-6. PubMed ID: 8322995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of atracurium-induced neuromuscular blockade by neostigmine or edrophonium.
    Astley BA; Hughes R; Payne JP
    Br J Anaesth; 1986 Nov; 58(11):1290-5. PubMed ID: 3778793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of edrophonium and neostigmine for the reversal of mivacurium-induced neuromuscular blockade in sheep.
    Clutton RE; Glasby MA
    Res Vet Sci; 1998; 64(3):265-6. PubMed ID: 9690616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reversal of profound mivacurium-induced neuromuscular blockade.
    Kao YJ; Le ND
    Can J Anaesth; 1996 Nov; 43(11):1128-33. PubMed ID: 8922768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of rapacuronium using edrophonium or neostigmine: pharmacodynamics and pharmacokinetics.
    Mills KG; Wright PM; Pollard BJ; Scott JM; Hing JP; Danjoux G; Hunter JM
    Br J Anaesth; 1999 Nov; 83(5):727-33. PubMed ID: 10690134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases.
    Beemer GH; Bjorksten AR; Dawson PJ; Dawson RJ; Heenan PJ; Robertson BA
    Br J Anaesth; 1991 Apr; 66(4):469-75. PubMed ID: 2025474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of rocuronium (Org 9426) by continuous infusion and its reversibility with anticholinesterases.
    McCoy EP; Mirakhur RK; Maddineni VR; Loan PB; Connolly F
    Anaesthesia; 1994 Nov; 49(11):940-5. PubMed ID: 7802236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neostigmine and edrophonium as antagonists of atracurium and pancuronium.
    Sanfilippo M; Vilardi V; Fierro G; Rosa G; Pelaia P; Gasparetto A
    Acta Anaesthesiol Scand; 1988 Aug; 32(6):437-40. PubMed ID: 2845694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium.
    Rupp SM; McChristian JW; Miller RD; Taboada JA; Cronnelly R
    Anesthesiology; 1986 Jun; 64(6):711-7. PubMed ID: 2872839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophonium.
    Caldwell JE; Robertson EN; Baird WL
    Br J Anaesth; 1986 Nov; 58(11):1285-9. PubMed ID: 2877681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of intense atracurium-induced neuromuscular block in children.
    Gwinnutt CL; Walker RW; Meakin G
    Br J Anaesth; 1991 Jul; 67(1):13-6. PubMed ID: 1859751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro neuromuscular effects of valproic acid.
    Nguyen A; Ramzan I
    Br J Anaesth; 1997 Feb; 78(2):197-200. PubMed ID: 9068341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.